Author

Kanoko Matsumura

Observed name: K. Matsumura

Institution: Takatsuki General Hospital

Observed institutions: Nippon Chemiphar (Japan), Takatsuki General Hospital

ORCID: 0000-0002-3342-3427

Observed ORCID: 0000-0002-3342-3427

OpenAlex ID: A5076670585

Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer

2023 · Kiyoko Fukuda, Naoko Katsurada, et al. · Heliyon · 11

TAPO in first‐line osimertinib therapy and continuation of osimertinib

2022 · Chihiro Mimura, Kazumi Kaneshiro, et al. · Thoracic Cancer · 7

Exacerbation of nontuberculous mycobacterial pulmonary disease in a patient with advanced non-small-cell lung cancer during treatment with PD-1 inhibitor and chemotherapy

2021 · Mariko Okamoto, Young Hak Kim, et al. · Respiratory Medicine Case Reports · 7

Diffuse and Strong TTF-1 Expression Predicts Response to Pemetrexed-Based Immunochemotherapy in Advanced Lung Adenocarcinoma

2025 · Jun Yamada, Naoe Jimbo, et al. · Cancer Management and Research · 4

Mechanism of action of adapalene for treating EGFR‐TKI ‐induced skin disorder

2024 · Chihiro Mimura, Tatsuya Nagano, et al. · Thoracic Cancer · 4

Potassium/Sodium Citrate Attenuates Paclitaxel-Induced Peripheral Neuropathy

2025 · Daisuke Uta, Hideki Nakamura, et al. · International Journal of Molecular Sciences · 2

ROS1-Rearranged Lung Cancer With Extensive Calcification on Computed Tomography: A Case Report

2024 · Junya Yoshioka, Kentaro Hizume, et al. · Cureus · 1

Drug-Induced Interstitial Lung Disease after Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer

2023 · Kiyoko Fukuda, Naoko Katsurada, et al. · SSRN Electronic Journal · 1

Prognostic Effect of TTF-1 Expression and Histopathology in the Patients with Advanced Lung Adenocarcinoma Treated with Immunochemotherapy.

2026 · Natsuhiko Iwamoto, Jun Yamada, et al. · PubMed

1474P Outcome of nivolumab and ipilimumab-based therapy for advanced non-small cell lung cancer with low or negative PD-L1 expression

2023 · T. Fukui, S. Hori, et al. · Annals of Oncology

Drug-Induced Interstitial Lung Disease after Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer

2023 · Kiyoko Fukuda, Naoko Katsurada, et al. · SSRN Electronic Journal

1141P A multicenter study of incidence of drug-induced lung disease in first-line osimertinib therapy and continuation of osimertinib administration

2022 · C. Mimura, M. Tachihara, et al. · Annals of Oncology

Works count: 12

Citation count: 37

H-index: 4

I10-index: 1